Effects of SCH23390 and raclopride on anxiety-like behavior in rats tested in the black-white box

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 323-327

  Timothy, Carryl ^a   Costall, Brenda ^a   Smythe, James W ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Anxiety; Black white box; Dopamine; Hippocampus; Raclopride; Rat; SCH23390; Stress

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; RACLOPRIDE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANXIETY; DOPAMINE ANTAGONISTS; MALE; MICE; MOTOR ACTIVITY; RACLOPRIDE; RATS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; TIME FACTORS;

EID: 0032933147     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00157-9     Document Type: Article

References (35)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effects of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial prefrontal cortex. J. Neurochem. 52:1989;1655-1658.
2. Andreatini R., Leite J.R. Evidence against the involvement of ACTH/CRF release or corticosteroid receptors in the anxiolytic effect of corticosterone. Braz. J. Med. Biol. Res. 27:1994;1237-1241.
3. Bradbury M.J., Akana S.F., Cascio C.S., Levin N., Jacobson L., Dallman M.F. Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J. Steroid Biochem. Mol. Biol. 40:1991;133-142.
4. Bray J.H., Maxwell S.E. Analyzing and interpreting significant MANOVAs. J. Educat. Res. 52:1982;340-367.
5. Cenci M.A., Kalen P., Mandel R.J., Bjorklund A. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen. A microdialysis study in the rat Brain Res. 581:1992;217-228.
6. 3 receptor antagonist, RS-42358-197, in animal models of anxiety. Eur. J. Pharmacol. 234:1993;91-99.
7. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Tomkins D.M. Exploration of mice in a black and white test box. Validation as a model of anxiety Pharmacol. Biochem. Behav. 32:1989;777-785.
8. Day J.C., Fibiger H.C. Dopaminergic regulation of septohippocampal cholinergic neurons. J. Neurochem. 63:1994;2086-2092.
9. Delacour J. A central activation role for the hippocampus. A viewpoint Neurosci. Res. Commun. 16:1995;1-10.
10. Dunn A.J., File S.E. Cold restraint alters dopamine metabolism in frontal cortex, nucleus accumbens and neostriatum. Physiol. Behav. 31:1983;511-513.
11. Feenstra M.G.P., Botterblom M.H.A., van Uum J.F.M. Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo. Inhibition by diazepam Neurosci. Lett. 189:1995;81-84.
12. Feldman S., Weidenfeld J. Neural mechanisms involved in the corticosteroid feedback effects on the hypothalomo-pituitary-adrenocortical axis. Prog. Neurobiol. 45:1995;129-141.
13. File S.E., Velluci S.V., Wendlandt S. Corticosterone - An anxiogenic or an anxiolytic agent? J. Pharm. Pharmacol. 31:1979;300-305.
14. Gilad G.M., Habey J.M., Gilad V.H. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neuronal interactions in stress. Life Sci. 40:1987;2401-2408.
15. Grace A.A., Bunney B.S. Induction of depolarization block in midbrain DA neurons by repeated administration of haloperidol. Analysis using in vivo intracellular recording J. Pharmacol. Exp. Ther. 238:1986;1092-1100.
16. Gratton A., Wise R.A. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J. Neurosci. 14:1994;4130-4146.
17. Gray J.A. The neuropsychology of anxiety. 1982;Oxford University Press, Oxford.
18. Hasselmo M.E. Neuromodulation and cortical function. Modelling the physiological basis of behavior Behav. Brain Res. 67:1995;1-27.
19. 1 receptors. A combined receptor autoradiagraphy and in vivo dialysis study J. Neurosci. 15:1995;7150-7157.
20. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures. Role of corticosterone Eur. J. Pharmacol. 165:1989;337-338.
21. Lavielle S., Tassin J.P., Thierry A.M., Blanc G., Herve D., Barthelemy C., Glowinski J. Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopamine neurons in the rat. Brain Res. 168:1978;585-594.
22. Meaney M.J., O'Donnell D., Viau V., Bhatnagar S., Sarrieau A., Smythe J.W., Shanks N., Walker C.D. Corticosteroid receptors in the rat brain and pituitary during development and hypothalamic-pituitary-adrenal (HPA) function. McLaughlin P., Zagon I. Receptors and the developing nervous system. 1993;163-201 Chapman and Hill, London.
23. Murphy D., Costall B., Smythe J.W. Yohimbine's anxiogenic effect in the black-white box can be reduced by chlordiazepoxide. confirmation of test validity for rats Br. J. Pharmacol. 119:1996;63P.
24. O'Donnell P., Grace A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons. Hippocampal gating of prefrontal cortical input J. Neurosci. 15:1995;3622-3639. -.
25. Roberts D.C.S., Koob G.F., Klonoff P., Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12:1980;781-787.
26. Roth R.H., Tam S.Y., Ida Y., Yang J.X., Deutch A.Y. Stress and the mesocorticolimbic dopamine systems. Ann. NY Acad. Sci. 537:1988;138-147.
27. Schultz W., Apicella P., Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J. Neurosci. 13:1993;900-913.
28. Simon P., Panissaud C., Costentin J. Anxiogenic-like effects induced by stimulation of dopamine receptors. Pharmacol. Biochem. Behav. 45:1993;685-690.
29. 1 dopamine receptor antagonist. Neuroreport. 3:1992;941-942.
30. Smythe J.W., Murphy D., Bhatnagar S., Timothy C., Costall B. Muscarinic antagonists produce anxiogenesis in rats tested in the Black-white box. Pharmacol. Biochem. Behav. 54:1996;57-63.
31. Smythe J.W., Murphy D., Timothy C., Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior (ALB) as assessed by the black-white box. Pharmacol. Biochem. Behav. 56:1997;507-513.
32. Smythe J.W., Bhatnagar S., Murphy D., Timothy C., Costall B. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box. Brain Res. Bull. 45:1998;89-93.
33. Smythe J.W., Murphy D., Timothy C., Costall B. Exogenous corticosterone is anxiogenic in rats tested in the black-white box. Br. J. Pharmacol. 118:1995;62P.
34. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of the mesocortical dopaminergic system by stress. Nature. 263:1976;242-244.
35. Wise R.A. Catecholamine theories of reward. A critical review Brain Res. 152:1978;215-247.